Abstract
Objectives: Clinical deterioration during the waiting time impairs the prognosis of patients listed for heart transplantation. Reduced muscle mass increases the risk for mortality after cardiac surgery, but its impact on resilience against deterioration during the waiting time remains unclear.Methods: We retrospectively analyzed data from 93 patients without a VAD who were listed in Eurotransplant status “high urgent (HU)” for heart transplantation between January 2015 and October 2020. The axial muscle area of the erector spinae muscles at the level of thoracic vertebra 12 indexed to body surface area (TMESA/BSA) measured in the preoperative thoracic computed tomography scan was used to measure muscle mass.Results: Forty patients (43%) underwent emergency VAD implantation during the waiting time and four patients (4%) died during the waiting time. The risk of emergency VAD implantation/death during the waiting time decreased by 10% for every cm2/m2 increase in muscle area [OR 0.901 (95% CI: 0.808–0.996); p = 0.049]. After adjusting for gender [OR 0.318 (95% CI: 0.087–1.073); p = 0.072], mean pulmonary artery pressure [OR 1.061 (95% CI: 0.999–1.131); p = 0.060], C-reactive protein [OR 1.352 (95% CI: 0.986–2.027); p = 0.096], and hemoglobin [OR 0.862 (95% CI: 0.618–1.177); p = 0.360], TMESA/BSA [OR 0.815 (95% CI: 0.698–0.936); p = 0.006] remained an independent risk factor for emergency VAD implantation/death during the HU waiting time.Conclusion: Muscle area of the erector spinae muscle appears to be a potential, easily identifiable risk factor for emergency VAD implantation or death in patients on the HU waiting list for heart transplantation. Identifying patients at risk could help optimize the outcome and the timing of VAD support.
Highlights
Cardiac transplantation remains the gold standard for end-stage heart failure, but donor organ shortage causes long waiting times even for critically ill patients in the Eurotransplant region [1, 2]
To the best of our knowledge, this is the first study investigating the impact of muscle mass on the prognosis during the waiting time of adult patients with a “high urgent (HU)” Eurotransplant status for heart transplantation [12, 13]
No difference was observed in secondary organ function represented by the glomerular filtration rate calculated with the Modification of Diet in Renal Disease (MDRD) formula and the Model For End-Stage Liver Disease XI (MELD-XI) score [21] (Table 1)
Summary
Cardiac transplantation remains the gold standard for end-stage heart failure, but donor organ shortage causes long waiting times even for critically ill patients in the Eurotransplant region [1, 2]. Several risk factors for waiting list mortality were identified, including impaired renal function and low serum albumin [4]. The reduced resilience against stressors [5], and sarcopenia, reduced muscle mass and function [6], appear to be relevant risk factors for waiting list mortality in patients undergoing kidney [7, 8], lung [9], or liver transplantation [10, 11]. To the best of our knowledge, this is the first study investigating the impact of muscle mass on the prognosis during the waiting time of adult patients with a “high urgent (HU)” Eurotransplant status for heart transplantation (comparable to UNOS status 3) [12, 13]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.